ArticleClinical ophthalmology (Auckland, N.Z.)2018

Ranibizumab treatment history as predictor of the switch-response to aflibercept: evidence for drug tolerance.

Ali Dirani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.